Structure of a benzosulfonamide based inhibitor 11l bound to a disulfide stabilised HIV-1 capsid hexamer
Barnett, M.; Sun, L.; Xu, S.; Liu, X.; Zhan, P.; Goldstone, D. C. C.
Show abstract
The Human Immunodeficiency Virus Type 1 (HIV-1) continues to be a major global health issue, with infection leading to Acquired Immunodeficiency Syndrome (AIDS). Despite advances in antiviral therapy, the need for new and more effective treatments remains critical. In this study, we determined the structure of the disulfide stabilised HIV-1 capsid protein hexamer in complex with the novel antiviral capsid inhibitor compound 11l. The structure revealed the presence of six 11l molecules bound to the capsid hexamer in a conserved site shared by nuclear import factors, and other capsid inhibitor compounds such as PF74 and GS-6207. The 11l compound exhibits disorder in the benzo-sulfonamide groups and disruption in the loop between helix 8 and 9 for the capsid C-terminal domain, an important 2-fold symmetry axis for hexamer formation. Our findings provide insights into the mechanism of action of 11l as a capsid inhibitor and antiviral. These results contribute to the ongoing efforts to develop more effective antiviral treatments for the global burden of HIV and AIDS. SynopsisInsight into the mechanism of action for a novel HIV-1 capsid inhibitor antivirals are elucidated by structure of HIV-1 capsid hexamer bound to the novel inhibitor compound 11l.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket 95%
- Possible Implications of AlphaFold2 for Crystallographic Phasing by Molecular Replacement 93%
- Statistically correcting dynamical electron scattering improves refinement of protein nanocrystals, including charge refinement of coordinated metals 92%
Similar papers in this journal
- Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity. 93%
- Near-Physiological-Temperature Serial Femtosecond X-ray Crystallography Reveals Novel Conformations of SARS-CoV-2 Main Protease Active Site for Improved Drug Repurposing 92%
- A common binding motif in the ET domain of BRD3 forms polymorphic structural interfaces with host and viral proteins 92%
Similar papers in this journal
- Structural analysis of the SARS-CoV-2 methyltransferase complex involved in coronaviral RNA cap creation 94%
- Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors 94%
- Structure, Mechanism and Crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase 93%
Similar papers in this journal
Similar papers in this journal
- Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2 94%
- {Omega}-Loop mutations control dynamics of the active site by modulating the hydrogen-bonding network in PDC-3 β-lactamase 92%
- Design of novel Cyanovirin-N variants by modulation of binding dynamics through distal mutations 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.